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We investigate the cell entry mechanism of the mem-
brane-lytic peptides K8L9 and melittin in cancer cell
lines. K8L9 and melittin interacted with the highly ex-
pressed endocytic receptors neuropilin-1, low-den-
sity lipoprotein-related protein receptor 1 (LRP1),
and transferrin receptor. Silencing of these receptors
by small interfering RNAs (siRNAs) attenuated the
cytotoxic activity of K8L9 in four cancer cell lines.
Intracellular K8L9 and melittin triggered enlargement
of the lysosomal compartments and cytosolic trans-
location of cathepsin B. Hsc70 was identified as a
melittin-interactive molecule using coimmunopreci-
pitation and mass spectrometry, and Hsc70-siRNA
attenuated the cellular uptake of K8L9 and cytotoxic
activity by K8L9 and melittin. These findings suggest
that K8L9 and melittin can enter cancer cells via re-
ceptor endocytosis following subcytotoxic treatment
and subsequently affect lysosomal compartments.
INTRODUCTION
Antimicrobial peptides (AMPs) play an important role in host de-
fense against bacterial pathogens. AMPs are naturally occurring
peptides found in plants, animals, bacteria, fungi, and synthetic
peptides (Zasloff, 2002; Shai and Oren, 2001). Many cationic
AMPs are unstructured in solution, but can form a-helical or b
strand secondary structures upon contact with the cell mem-
brane. Concentrated cationic moieties on molecules with a
strong amphipathic structure bind to lipid headgroups of the
anionic microbial cell membrane while the nonpolar side is
exposed to the membrane acyl core and disrupts the membrane
bilayer by forming pores (Zasloff, 2002; Brogden, 2005). Different
models have been proposed to account for the mechanism of
membrane disintegration induced by membrane-lytic peptides
(MLPs), namely the barrel stave, toroidal pore, and detergent-
like models (Hoskin and Ramamoorthy, 2008). Some AMPs
exhibit cytotoxic activity against cancer cells, whose outer mem-
brane contains 3% to 9% negatively charged phosphatidylser-
ine, which is slightly higher than that in normal cells (Papo and
Shai, 2003).1522 Chemistry & Biology 21, 1522–1532, November 20, 2014 ª2014Several naturally occurring AMPs that exhibit anticancer activ-
ity have been identified, for example, melittin from the venom of
honeybees, magainins from the skin of the African clawed frog,
and buforins from the stomach of the Korean toad (Zasloff,
2002; Hoskin and Ramamoorthy, 2008). These AMPs not only
disrupt the cell membrane but can also enter the cytoplasm
and affect various intracellular targets. Melittin stimulates phos-
pholipase A2 and D and reduces the activity of IkB kinase (Park
et al., 2007; Lee et al., 2001). Magainin 2 and buforin 2 exert cyto-
toxic activity against cancer cells without damaging cell mem-
branes by disrupting mitochondrial functions (Cruz-Chamorro
et al., 2006; Lee et al., 2008). Histatin 5, found in human salivary
secretions, and ApoEdpL-W (human ApoE apolipoprotein deriv-
ative) exert antifungal activity in Candida albicans via endocy-
tosis (Mochon and Liu, 2008; Rossignol et al., 2011).
Cationic membrane-active peptides (MAPs) include not only
AMPs, but also amyloid b peptide and cell-penetrating peptides
(CPPs) (Last et al., 2013). Some MAPs are known to enter the
cell via endocytosis. Amyloid b peptide enters the cytoplasm
via low-density lipoprotein receptor-related proteins (LRPs)
and the receptor for advanced glycation end products (RAGEs)
and subsequently disrupts mitochondrial functions (Takuma
et al., 2009; Deane et al., 2004). It is reported that stearylated
K6L9, an MLP, delivers plasmids into cells by clathrin- and cav-
eolin-mediated endocytosis (Zhang et al., 2013a).
We recently showed that the lytic peptide K8L9 can enter the
cytoplasm via endocytosis-dependent or -independent path-
ways (Ohara et al., 2013). We hypothesized that some MLPs
might interact with receptors and enter cells via endocytosis in
a similar fashion to the peptides mentioned above. In this study,
we demonstrate that K8L9 and melittin interact with receptors
and enter the cytoplasm via endocytosis. We try to identify the
molecules with which artificial and natural peptides, K8L9 and
melittin, respectively, interact to achieve cellular entry, and we
analyze the intracellular trafficking of the peptides.
RESULTS
K8L9 Not Only Disrupts Cell Membranes from the
Outside, but Also Enters the Cytoplasm via Endocytosis
following Subcytotoxic Exposure
We previously showed that endocytosis inhibitors attenuate the
cytotoxic activity and cellular uptake of the lytic peptide K8L9
in U251 cells. To investigate this phenomenon in other humanElsevier Ltd All rights reserved
Figure 1. K8L9 Not Only Disrupts the Cell
Membrane from the Outside, but Also En-
ters the Cytoplasm
(A) Effect of endocytosis inhibitors on K8L9 cyto-
toxicity. Cells were pretreated with the actin
polymerization inhibitor cytochalasin D (CD, 0.75–
1.00 mM) or the clathrin inhibitor chlorpromazine
(CPZ, 10 mM) for 1 hr prior to incubation with 10–
20 mM K8L9 for a further 24 hr. The results are
represented as the means ± SD (bars) of three or
four independent experiments. *p < 0.05, **p <
0.01.
(B) Effect of endocytosis inhibitors on cellular up-
take of K8L9-FITC peptide. Cellular uptake of
K8L9-FITC (KF) was determined by flow cy-
tometry. The bar charts indicate the mean fluo-
rescence intensity (MFI) after normalization to cells
incubated with K8L9-FITC alone. The results are
represented as the means ± SD (bars) of three
independent experiments. *p < 0.05, **p < 0.01.
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Lytic Peptide Enters Cells via Endocytic Receptorcancer cell lines, we used the acute monocytic leukemia and
pancreatic cancer cell lines THP1 and SU8686, respectively.
The viability of cells treated with K8L9 increased after pretreat-
ment with the actin polymerization inhibitor cytochalasin D or
the clathrin inhibitor chlorpromazine (Figure 1A). On the other
hand, cytotoxic activity of L-K8L9 containing all L amino acids
was weakly inhibited by actin polymerization inhibitor compared
with that of K8L9 (Figure S1 available online). Pretreatment of
cells with cytochalasin D or chlorpromazine decreased the
cellular uptake of K8L9-fluorescein isothiocyanate (FITC) (Fig-
ure 1B). These results suggest that K8L9 not only disrupts the
cell membrane from the outside, but also enters the cytoplasm
via endocytosis following subcytotoxic exposure.
Membrane Attack by K8L9 Is Moderate Compared with
that by K6L9 and Melittin
To create a molecular-targeted anticancer drug with a novel
mode of action, we designed the lytic peptide K8L9, which
moderately attacks cell membranes compared with conven-
tional membrane disrupting peptides (Kohno et al., 2011). Since
we hypothesized that the moderate membrane attack activity of
K8L9, when compared with more potent MAPs, facilitates its
cellular uptake via endocytosis, we assessed the concentration
and time-dependent cytotoxic activity of melittin, K6L9, and
K8L9. Cytotoxicity was observed in cells treated for 24 hr with
5 mM melittin and 7.5 mM K6L9, but not in cells treated with
10 mMK8L9 (Figure 2A; Table S1). K8L9 has antimicrobial activity
against E. coli., and its IC50 value against JM109 was 2.9 ±
0.21 mM (Figure S2).
We proceeded to compare the membrane attack activity of
the three peptides in U251 and H460 cells. Cells were treated
with 30 mM K8L9, 10 mM K6L9, or 5 mM melittin for 1 hr or
24 hr. In 1 hr exposure, K8L9 showed less cytotoxic activity
when compared with melittin and K6L9 (Figure 2B). The cyto-
toxic activity and cellular uptake of melittin were only weakly
attenuated by endocytosis inhibitors compared with K8L9 (Fig-
ure S3). These results suggest that it is easier to detect K8L9Chemistry & Biology 21, 1522–153cellular uptake via endocytosis because it only moderately dis-
rupts cell membranes when compared with more potent MAPs.
Interaction of K8L9 and Melittin with Endocytic
Receptors
It has previously been reported that amyloid b peptide enters
cells via LRP1 and RAGE (Takuma et al., 2009; Deane et al.,
2004) and that C end rule peptide, containing a C-terminal argi-
nine/lysine, enters cells via neuropilin 1 (NRP1) (Teesalu et al.,
2009). These receptors interact with the cationic peptides and
translocate them to the intracellular space via endocytosis. We
focused on highly expressed endocytosis receptors in cancer
cell lines and examined whether K8L9 and melittin could interact
with them. NRP1 and LRP1 were highly expressed in pancreatic
cancer and glioma cell lines SU8686 and U251, respectively,
whereas transferrin receptor (TfR) was highly expressed in lung
cancer H460 and breast cancer T47D cell lines (Figure 3A). We
investigated the interaction of these receptor on K8L9 and melit-
tin by coimmunoprecipitation and western blotting using bio-
tinylated K8L9 or melittin and NeutrAvidin resins. In the presence
of melittin-biotin, clear interaction bands were observed for
NRP1 and TfR, but no bands were observed in the presence or
absence of K8L9-biotin (Figure 3B).
To compare the binding affinity of cationic peptides to NRP1,
the binding of K8L9, melittin, and magainin 2 to immobilized
NRP1 on the surface of sensor chips was monitored using a Bia-
core analyzer. While NRP1 was not coimmunoprecipitated with
K8L9 but with melittin, increment of the concentration of K8L9
and melittin clearly increased their binding to NRP1, with Kd
values of 9.23 3 105 M and 2.03 3 106 M obtained for K8L9
and melittin, respectively (Figure 3C; Table S2). On the other
hand, the increment of sensorgrams between magainin 2 and
NRP1 was also found in the concentration-dependent manner
of the peptides, but the Kd value for the interaction was 3.30 3
104 M, which was approximate 100-fold higher than that of me-
littin (Figure 3C; Table S2). Judging from the shape of curve after
stopping the injection, dissociation of K8L9 was notably faster2, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1523
Figure 2. K8L9 Is Less Cytotoxic than K6L9
and Melittin
(A) U251, H460, and SU8686 cancer cell lines were
cultured with various concentrations of K8L9 (left
panel), K6L9 (middle panel), or melittin (right panel)
for 24 hr, and cell viability was assessed using
WST-8 reagent. The results are presented as the
mean ± SD (bars) of triplicate determinations and
were confirmed from the repeated experiments
three or four times (Table S1).
(B) U251 and H460 were treated with 30 mM K8L9
(left panel), 10 mM K6L9 (middle panel), or 5 mM
melittin (right panel) for 1 hr (gray columns) or 24 hr
(black columns) before the peptide-containing
medium was replaced with fresh medium for a
further 24 hr culture. Cell viability was analyzed
using WST-8. The results are represented as
the means ± SD (bars) of three or four indepen-
dent experiments. *p < 0.05, **p < 0.01. n.s., not
significant.
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Lytic Peptide Enters Cells via Endocytic Receptorthan that of melittin, and we believe this to explain why no copre-
cipitation of NRP1 was observed with K8L9-biotin (Figure 3B).
The binding affinity of magainin 2 to NRP1 was notably lower
than that of K8L9 andmelittin; also, the cytotoxic activity of mag-
ainin 2 was also weaker than K8L9 and melittin and only weakly
attenuated by endocytosis inhibitors (Figure S4 and Table S3).
We proceeded to assess whether K8L9 induces downregula-
tion of the endocytic receptors NRP1 and TfR. Incubation of
SU8686 or T47D cells with K8L9 downregulated NRP1 or TfR,
respectively (Figures 3D and S5). These results suggest that
K8L9 and melittin interact with NRP1 and TfR.
Participation of Receptors in Cellular Uptake and
Cytotoxic Activity of K8L9 and Melittin
To determine the potential role of receptors in the cellular uptake
of K8L9 and melittin, the effect of siRNAs on each receptor was
examined. Four cancer cell lines were transiently transfected
with a negative control siRNA (siNC) or siRNAs specific to
LRP1, NRP1, or TfR. The efficiency of gene knockdown was
determined by western blot analysis. Knockdown of each recep-
tor typically resulted in decreased K8L9-FITC uptake but did
not change melittin-FITC uptake (Figure 4A). To determine the
potential role of the receptors in the cytotoxic activity of K8L9
and melittin, the effect of each siRNA on cell viability was
examined. K8L9 cytotoxicity was attenuated by knockdown of
each receptor in all four cancer cell lines whereas the cytotoxicity
of melittin was only attenuated by knockdown of LRP1 and TfR
in U251 and H460 cell lines, respectively (Figure 4B; Table S4).
These results suggest that K8L9 and melittin interact with
NRP1, LRP1, and TfR, enter the cytoplasm via endocytosis,
and affect cell damage outside and inside the plasma
membrane.
Hsc70 Is One of the Interaction Partners of Melittin and
K8L9
We tried to identify novel interaction partners of K8L9 and melit-
tin by coimmunoprecipitation andmass spectrometry. U251 and
H460 cells were treated with K8L9-biotin or melittin-biotin, and1524 Chemistry & Biology 21, 1522–1532, November 20, 2014 ª2014cell lysates were prepared. Complexes that formed with K8L9-
biotin or melittin-biotin were captured using NeutrAvidin resin.
The associated proteins were separated by SDS-PAGE and
visualized by silver staining (Figure S6). Bands were excised
from the gel and subjected to trypsin digestion, and the resulting
peptides were analyzed by mass spectrometry. All bands were
divided into nine groups (A–I) and liquid chromatography-mass
spectrometry (LC-MS/MS) analyzed nine groups as one sample
mixed with four or five bands and revealed an interaction of K8L9
andmelittin with actins, tubulins, vimentin, elongation factor 1-a,
methylcrotonoyl-CoA carboxylase b chain, and 40S/60S ribo-
somal proteins (Table S5). From these results, we focused on a
protein chaperone, heat shock cognate 70 kDa (Hsc70) (Fig-
ure 5A). Since it is known that Hsc70 participates in endocytosis,
chaperon-mediated autophagy, and virus entry, we hypothe-
sized that Hsc70 may represent a novel and interesting interac-
tion partner of melittin or K8L9. The interaction between Hsc70
and these peptides was further investigated by coimmunopreci-
pitation using NeutrAvidin resins and western blotting for Hsc70.
Clear interaction bands for Hsc70 were detected in the presence
of melittin-biotin only; no band was observed in the presence or
absence of K8L9-biotin in any of the four cancer cell lines tested
(Figure 5B). To compare the binding affinities of K8L9, melittin,
and magainin 2 for Hsc70, binding to immobilized-Hsc70 on
the surface of sensor chips was monitored using a Biacore
analyzer. Increasing concentrations of K8L9 and melittin clearly
increased Hsc70 binding, with Kd values of 6.02 3 105 M and
1.26 3 106 M obtained for K8L9 and melittin, respectively (Fig-
ure 5C and Table S2). It was also found that the binding affinity of
Magainin 2 (2.423 104M) to Hsc70was lower than that of K8L9
and melittin (Figure 5C; Table S2).
Participation of Hsc70 in Cellular Uptake and Cytotoxic
Activity of K8L9 and Melittin
To determine the potential role of Hsc70 in the cellular uptake of
K8L9 and melittin, the effect of siRNA-mediated knockdown of
Hsc70 was examined. Four cancer cell lines were transiently
transfected with either Hsc70-specific siRNA or siNC. In all theElsevier Ltd All rights reserved
Figure 3. Interaction of K8L9 and Melittin with Endocytosis Receptors
(A) Analysis of NRP1, TfR, and LRP1 expression in cancer cell lines. Cell extracts from the indicated cancer cell lines were examined for NRP1, TfR, and LRP1
expression by western blot analysis using corresponding antibodies. b actin was used as a loading control. Bands were visualized by chemiluminescence.
(B) Immunoprecipitation of receptors associated with a biotinylated K8L9 or melittin. Whole-cell lysates were prepared from cancer cells incubated with K8L9-
biotin or melittin-biotin andNeutrAvidin agarose resinswere used to capture the proteins associatedwith the biotinylated peptides. Receptors were subsequently
detected by western blotting.
(C) Sensorgrams of melittin, K8L9, or magainin 2 bound to immobilized NRP1, as determined using a Biacore biosensor. All peptides, melittin (1.25, 2.5, 5, 8, 10,
and 12.5 mM), K8L9 (12.5, 25, 50, 80, 100, and 125 mM), or magainin 2 (12.5, 25, 50, 80, 100, and 125 mM) were injected over immobilized-NRP1, and the progress
of binding was monitored by following the increase in the signal (response) induced by the analytes. Each analyte was injected in triplicate (n = 3), and three
independent assays were performed for determination of dissociation constant (KD) values. The thin and thick arrows indicate the initiation and termination of
injection, respectively. Response was measured in resonance units (RUs).
(D) Western blot showing that K8L9 induced downregulation of NRP1 and TfR (upper panel, a typical example). The blots were stripped and incubated with an
antibody against b actin, and the NRP1 or TfR bands were normalized to b actin levels using Image-J software and plotted on a bar graph as the means ± SD of
three or four independent experiments (lower panel). **p < 0.01.
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Lytic Peptide Enters Cells via Endocytic Receptorcancer cell lines, Hsc70 knockdown decreased K8L9-FITC up-
take but did not change melittin-FITC uptake (Figure 6A). To
determine the potential role of Hsc70 in the cytotoxic activity
of K8L9 and melittin, the effect of Hsc70 siRNA on cell viability
was examined. The cytotoxic activity of K8L9 and melittin was
typically attenuated by Hsc70 knockdown in all four cancer cell
lines (Figure 6B; Table S6). These results suggest that K8L9
andmelittin interact with Hsc70 and that Hsc70 could participate
in cell entry and cytotoxic activity of K8L9 and melittin.
K8L9 Alters Lysosomal Compartments
It is known that Hsc70 participates in chaperone-mediated auto-
phagy by binding to cytosolic proteins and transporting them
to the lysosome (Stricher et al., 2013). We tried to detect the
autophagic phenomena stimulated by intracellular K8L9. The
cytotoxic activity of K8L9 was attenuated by the autophagic in-
hibitors chloroquine and E64d (Figure S7A). To monitor the
behavior of the compartments that are sequentially formed inChemistry & Biology 21, 1522–153autophagic flux, we first used the autophagic fluorescent probe,
monodansylcadaverine (MDC), which can be quantitated by flow
cytometry. A concentration-dependent increase in MDC fluores-
cence intensity was observed in U251 cells treated with K8L9
(Figure S7B). However, no enhancement of p62 expression,
functional markers for autophagy, was observed in U251 and
H460 cells treated with K8L9 (Figure S7C). Since the cytotoxic
activity of K8L9 was attenuated by the cathepsin B inhibitor
E64d, we hypothesized that K8L9 may alter the characteristics
of lysosomal compartments.
We next analyzed the effect of K8L9 and melittin exposure on
total cellular and cytosolic cathepsin B activity. K8L9 decreased
the total cellular cathepsin B activity but increased cytosolic
release of cathepsin B (Figure 7A, upper and lower panels,
respectively). Melittin exposure weakly increased cytosolic
release of cathepsin B (Figure 7A, lower panel). To monitor the
lysosomal compartments, we used the lysosomotropic dye
Lysotracker Green (LTG) and pH-probe Lysosensor blue, which2, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1525
Figure 4. Participation of Receptors in
Cellular Uptake of K8L9 and Melittin
(A) Effect of receptor siRNAs on K8L9-FITC and
melittin-FITC cellular uptake. Cells were trans-
fected with siRNAs specifically targeted against
LRP1 (U251), TfR (H460 and T47D), or NRP1
(SU8686) for 72 hr prior to treatment with 3 mM
K8L9-FITC (left panel) or 1 mM melittin-FITC (right
panel) for an additional 1 hr. Uptake was quanti-
tated as MFI. The results are represented as the
means ± SD (bars) of three independent experi-
ments. *p < 0.05, **p < 0.01. NC, negative control;
n.s., not significant.
(B) Effect of receptor-siRNA on K8L9 cytotoxicity.
Cells were transfected with siRNA specifically tar-
geted against TfR, LRP1, or NRP1 for 72 hr prior to
treatment with vehicle, K8L9 (K) ormelittin (M) at the
indicated concentrations for an additional 24 hr.
The results are presented as the mean ± SD (bars)
of triplicate determinations and were confirmed
from the repeated experiments three or four times
(Table S4).
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A concentration-dependent increase in LTG or Lysosensor fluo-
rescence intensity was observed in U251 cells treated with
K8L9 and melittin (Figures 7B and S7D), and K8L9-TAMRA
partially colocalized with the lysosome marker LTG (Figure 7C).
Finally, we assessed the participation of Hsc70 on the effects
of K8L9 on lysosomal compartments. Hsc70-siRNA inhibited
the K8L9-stimulated increase in cytosolic release of cathepsin
B and lysosomal compartments in U251 cells (Figure 7D).
These data suggest that intracellular K8L9 alters lysosomal
compartments.
DISCUSSION
We demonstrated that K8L9 and melittin are taken up into the
cells via endocytic receptors and can subsequently affect
lysosomal compartments. MAPs are classified into main three
families, AMPs, CPPs, and amyloid b peptide, according to
their initial apparent activity. They all share certain characteris-
tics—namely, they are short (<50 amino acids), amphipathic,
readily soluble in both aqueous and membrane environments
and contain cationic sequences to mediate their interaction with
negatively charged membrane components (Last et al., 2013).
CPPs are widely used as a powerful tool for a noninvasive
cellular delivery of nucleic acids, peptides/proteins, and nano-
particles. Three representative CPPs, HIV-1 transactivator of
transcription (Tat) protein-derived Tat peptide, antennapedia
Drosophila homeodomain-derived Antp peptide, and artificial
oligoarginine peptide have been extensively investigated and uti-
lized for drug delivery, diagnostics, gene therapy, and various
research applications. CPPs include many important sequences
in cell entry and cellular traffic of virus such as TAT and antp. It is
considered that there are many similarities between CPPs and1526 Chemistry & Biology 21, 1522–1532, November 20, 2014 ª2014 Elsevier Ltd All rightsvirus in cell entry, cellular traffic, and endo-
somal escape, etc. (Varkouhi et al., 2011;
Plank et al., 1998; Futaki et al., 2003).
CPPs are known to enter cells by two prin-cipal mechanisms: direct cell membrane penetration and endo-
somal pathways. It has been reported that CPPs are internalized
into the cytoplasm by several endosomal pathways, namely
macropinocytosis, clathrin-mediated endocytosis, and caveo-
lae-mediated endocytosis (Ra¨a¨gel et al., 2010). Most CPPs are
positively charged and are known to interact with negatively
charged heparin sulfate proteoglycans on the cell membrane.
Through this interaction, CPPs can effectively stimulate endocy-
tosis via clustering glycosaminoglycans (GAGs), cell signaling,
andactin rearrangements (Nakase et al., 2007). In addition to trig-
gering endocytosis through GAGs, CPPs can also interact with
cell surface receptors to stimulate cellular entry. It is reported
that oligoarginine peptides can interact with CXCR4 or the lami-
nin receptor to enter the cell via macropinocytosis (Tanaka
et al., 2012; Zhou et al., 2012). Ezzat et al. (2012) demonstrated
that PepFect14, a peptide nanocomplex with oligonucleotides,
can enter cells via scavenger receptors, while Kondo et al.,
(2012) discovered tumor lineage-homing CPPs and demon-
strated that CPP44 entered myelogenous leukemia cells via the
M160 scavenger receptor family. Furthermore, TAT, antp, and
oligoarginine are reported to induce internalization of the tumor
necrosis factor (TNF) receptor (Fotin-Mleczek et al., 2005).
Amyloid b peptides are known to interact with various cell
surface receptors, in particular, LRP1, RAGE, a7 nicotinic acetyl-
choline receptor, N-methyl-D-aspartic acid (NMDA) receptor,
methanotrophic glutamate receptor, and p75 neurotrophin re-
ceptor (Takuma et al., 2009; Deane et al., 2004; Snyder et al.,
2005; Renner et al., 2010; Nagele et al., 2002; Yamamoto
et al., 2007). As mentioned above, three families of MAPs share
similarities in how they attach and disintegrate the cell mem-
brane and how they enter the cytoplasm. Furthermore, for
some MAPs, receptor-mediated internalization is not restricted
to a single receptor.reserved
Figure 5. Hsc70 Is One of the Interaction
Partners of Melittin and K8L9
(A) Immunoprecipitation of proteins associated with
a biotinylated K8L9 or melittin. Whole-cell lysates
were prepared from U251 cells treated with K8L9-
biotin or melittin-biotin. Associated proteins were
immunoprecipitatedwithNeutrAvidinandseparated
bySDS-PAGEprior tovisualizationby silver staining.
(B) Immunoprecipitation of Hsc70 with biotinylated
K8L9 or melittin. Whole-cell lysates were pre-
pared from cancer cells treated with K8L9-biotin
or melittin-biotin, and associated proteins were
captured using NeutrAvidin agarose resins. Hsc70
was detected by Western blotting.
(C) Sensorgrams of melittin, K8L9, or magainin 2
bound to immobilizedHsc70, as determined using a
Biacorebiosensor.All peptides,melittin (1.25, 2.5, 5,
8, 10, and 12.5 mM), K8L9 (12.5, 25, 50, 80, 100,
125 mM), or magainin 2 (12.5, 25, 50, 80, 100, and
125 mM)were injected over immobilized Hsc70 and,
the progress of binding was monitored by following
the increase in the signal (response) induced by the
analytes. Each analyte was injected in triplicate (n =
3), and three independent assays were performed
for determination of dissociation constant (KD)
values. The thin and thick arrows indicate the initia-
tion and termination of injection, respectively.
Response was measured in resonance units (RUs).
Chemistry & Biology
Lytic Peptide Enters Cells via Endocytic ReceptorWhen considering the mechanism of receptor internalization
by MAPs, it is interesting to consider that epidermal growth
factor receptor (EGFR) can be ligand-independently activated
and internalized by different stress factors including g radiation,
ultraviolet, oxidants, lipid rafts disruption, heat shock, andHsp70
(Evdonin et al., 2006; Prenzel et al., 2001; Lambert et al., 2008).
Based on this information, we hypothesize that K8L9 andmelittin
stimulate receptor internalization by perturbation of the cell
membrane structure, including lipid rafts, triggering activation,
and internalization of some cell membrane receptors, including
some endocytic receptors, depending on the specific profile of
receptor expression in a given cell line. Further investigation is
required to test this hypothesis.
It is known that some cationic amphiphilic peptides and AMPs
facilitate endosomal escape for cytosolic delivery, andmodifica-
tions of these peptides have been reported to be useful for cyto-
solic delivery (Varkouhi et al., 2011). For example, although K6L9
andmelittin have strongmembrane-lytic and cytotoxic activities,
stearylated versions of these peptides exhibit higher transfection
efficiency and lower cytotoxicity (Zhang et al., 2013a, 2013b).
Stearylation enables enhanced compaction of nucleic acids,
facilitates endosomal escape, and reduces cytotoxic activity
(Zhang et al., 2013a). K8L9 exhibitedmoderatedmembrane-lytic
and cytotoxic properties compared with K6L9 (Figures 2A
and 2B) and is thought to facilitate endosomal escape similar
to the above peptides. K8L9 stimulated the cytosolic release of
cathepsin B from lysosomes in the cells treated with the peptide
(Figure 7A), and it is possible that intracellular trafficking of K8L9
is similar to that of the stearylated peptides mentioned above.
Inhibition of cell entry of K8L9 by endocytosis inhibitors or siRNA
of endocytosis-receptors decreased the cytotoxic activity of
K8L9. It is considered that intracellular K8L9 could induce the
damage of cell function against U251 cells.Chemistry & Biology 21, 1522–153In U251 cells treated with K8L9, increased lysosomal volume
using LTG and vacuolization of the cytosol was observed (Fig-
ure 7B; data not shown). This phenomenon is known to be
induced by long-term exposure to low concentrations of lyso-
somotropic compounds (Funk and Krise, 2012; Aki et al.,
2012). In neutral pH conditions, these compounds are un-
charged and can easily penetrate membranes, including
those of lysosomes, but in the acidic environment of lysosomes,
they become charged by protonation, cannot cross the lyso-
somal membrane, and become trapped in the lysosomes.
Lysosomal compartments accumulating lysosomotropic com-
pounds become enlarged and vacuolated by the influx of water
(Agostinelli and Seiler, 2007). Lysosomotropic compounds have
a lipophilic moiety and a basic moiety, similar to MLPs. Intraen-
dosomal K8L9 is also presumed to become charged by proton-
ation in low pH environments, leading to water influx and
enlargement, which facilitates leakage or rupture of the lyso-
somal membrane.
We showed that Hsc70, identified as a melittin-interactive
molecule, affected the cellular uptake and cytotoxic activity
of melittin and K8L9. Heat shock cognate protein 70, Hsc70,
belongs to the heat shock protein 70 (Hsp70) family, although
Hsc70 is a constitutively expressed chaperone, whereas
Hsp70 is inducible. Hsc70 and Hsp70 show some similarity in
structure and function. Hsc70 contains two functional domains:
the N-terminal ATPase domain and the C-terminal substrate
binding domain. Hsc70 resides in the cytosol, nucleus, and
close to membranes; prevents the aggregation of denatured,
misfolded, or newly synthesized proteins; and takes part in
cellular processes such as chaperone mediated autophagy
and uncoating of clathrin-coated endosomes (Liu et al., 2012).
It is reported that both Hsp70 and Hsc70 are released into the
extracellular space, reside on the cell surface, and are required2, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1527
Figure 6. Participation of Hsc70 in Cellular
Uptake of K8L9 and Melittin
(A) Effect of Hsc70-siRNA on cellular uptake of
K8L9-FITC and melittin-FITC peptides. Cells were
transfected with Hsc70-siRNA for 72 hr prior to
treatment with 3 mMK8L9-FITC (left panel) or 1 mM
melittin-FITC (right panel) for an additional 1 hr.
Uptake was quantitated as MFI. The results are
represented as the means ± SD (bars) of three or
four independent experiments. *p < 0.05, **p <
0.01. NC, negative control; n.s., not significant.
(B) Effect of Hsc70-siRNA on K8L9 cytotoxicity.
Cells were transfected with Hsc70-siRNA for 72 hr
prior to treatment with vehicle, K8L9 (K), or melittin
(M) at the indicated concentrations for an addi-
tional 24 hr. The results are presented as the
mean ± SD (bars) of triplicate determinations, and
were confirmed from the repeated experiments
three to six times (Table S6).
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ment (Schmitt et al., 2007; Mambula et al., 2007; Novoselova
et al., 2005). Some viruses, including rotavirus, reovirus, and
hepatitis B virus, require Hsc70 for entry and infection of host
cells (Pe´rez-Vargas et al., 2006; Ivanovic et al., 2007; Wang
et al., 2010). Histatins 3 and 5, AMPs, and telomerase-derived
CPP mixed with nucleic acids also enter cells via Hsp70 family
members (Sun et al., 2008; Li et al., 2003; Lee et al., 2013). In
neurological disease, Hsp70 family proteins attenuate aggrega-
tion and cytotoxicity associated with a synuclein, amyloid b, and
polyglutamine in the intracellular and extracellular environment
(Novoselova et al., 2005; Evans et al., 2006; Pemberton et al.,
2011). Candidate molecules that are reported to assist in the
transport of HSPs across the membrane include scavenger re-
ceptors, toll-like receptors, ABC transporters, flipping/flopping,
and LRP1 (Basu et al., 2001; The´riault et al., 2006; Mambula
and Calderwood, 2006). Quality control of proteins by HSPs
has been investigated both intracellularly and within the mem-
brane environment. De Maio (2011) proposed that the stress
observation system performed by HSPs could extend to the
extracellular, as well as intracellular, environment. According to
this view, Hsc70 would participate in the cellular entry of some
MAPs, including K8L9 and melittin, similar to viral infection.
It was previously reported that cationic L-CPPs were taken up
more efficiently than their D counterparts in MC57 fibrosarcoma
and HeLa cells (Verdurmen et al., 2011). On the other hand,
L-K8L9 containing all L amino acids showed stronger cytotoxic
activity and weaker sensitivity for endocytosis inhibitors than
K8L9 containing five D amino acids (Figure S1). Many AMPs
could have a potential as CPP by some suitable improvements
such as introducing stearyl moiety (stearylated K6L9) and arran-
ging D amino acids (K8L9). In this case, it is considered that suit-
able balance in membrane-lytic activity, cell entry, cytotoxicity,
and endosomal escape is important. In this study, we investi-1528 Chemistry & Biology 21, 1522–1532, November 20, 2014 ª2014 Elsevier Ltd All rights rgated the cell entry via receptor endocy-
tosis and cellular traffic of K8L9 andmelit-
tin. These sorts of studies in the cell entry
and cellular traffic of MLPs and compari-
son between MLPs and CPPs may be
useful for creating more excellent CPPsbased on MLP/AMPs and promoting investigations of the
cellular entry mechanisms of various exogenous molecules.
SIGNIFICANCE
We recently showed that theMLPK8L9 enters the cytoplasm
via endocytosis-dependent and -independent pathways
(Ohara et al., 2013). We hypothesized that some MLPs
interact with extracellular receptors and enter the cell via
endocytosis in a similar manner to amyloid b and CPPs. In
this study, we demonstrated that K8L9 and melittin interact
with receptors and enter the cytoplasm via endocytosis,
tried to identify the molecules with which K8L9 and melittin
interact, and analyzed the intracellular trafficking of K8L9
and melittin.
K8L9 and melittin interacted with the highly expressed
endocytosis-receptors, NRP1, LDL-related protein receptor
1, and TfR. Silencing of these receptors by siRNAs attenu-
ated the cytotoxic activity of K8L9 in four cancer cell lines.
Intracellular K8L9 and melittin-triggered enlargement of
the lysosomal compartments and cytosolic translocation
of cathepsin B. Coimmunoprecipitation and mass spec-
trometry identified Hsc70 as a molecule that interacts with
melittin. Knockdown of Hsc70 by siRNA attenuated the
cellular uptake and cytotoxic activity of K8L9 and melittin.
These findings suggest that K8L9 and melittin can enter
cancer cells via receptor endocytosis following subcyto-
toxic exposure and subsequently affect the lysosomal
compartments.
Many AMPs, including K8L9, could have a potential as
CPP by some improvements such as stearylated K6L9. In
this case, it is considered that suitable balance in mem-
brane-lytic activity, cell entry, cytotoxicity, and endosomal
escape is important. In this study, we investigated the celleserved
Figure 7. K8L9 and Melittin Alter Lysosomal Compartments
(A) The total cellular activity (upper panel) and the cytosolic release (lower panel) of cathepsin B were measured using z-RR-MCA, a fluorogenic probe, after 24 hr
of drug treatment. The results are represented as the means ± SD (bars) of three to seven independent experiments. *p < 0.05, **p < 0.01.
(B) The volume of acidic compartments in U251 cells was analyzed after treatment with K8L9 (K) or melittin (M) for 24 hr by LTG staining and flow cytometry. The
results are represented as the means ± SD (bars) of five independent experiments. *p < 0.05, **p < 0.01.
(C) Fluorescence signals from the K8L9-TAMRA peptide (red) and lysosome marker LTG distributed in the cytoplasm of U251 cells. Some K8L9-TAMRA are
colocalized with LTG.
(D) Effect of Hsc70-siRNA on lysosomal compartments in U251 cells treated with K8L9. Cytosolic cathepsin B activity was measured using z-RR-MCA, a
fluorogenic probe, after 24 hr of K8L9 or chloroquine (CQ) treatment (upper panel). The volume of acidic compartments was analyzed after treatment with 10 mM
K8L9 for 24 hr by LTG and flow cytometry (lower panel). The results are represented as themeans ± SD (bars) of three to five independent experiments. *p < 0.05.
NC, negative control; n.s., not significant.
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and melittin. These sort of studies in the cell entry and
cellular traffic of MLPs and comparison between MLPs
and CPPs may be useful for creating more excellent CPPs
based on MLP/AMPs and promoting investigations of the
cellular entry mechanisms of various exogenous molecules.EXPERIMENTAL PROCEDURES
Peptides
The following peptides were purchased from Invitrogen or American Peptide
Company (bold and italic letters are D amino acids):
(1) K8L9: KLLLKLLKKLLKLLKKK-OH
(2) K8L9-FITC: KLLLKLLKKLLKLLKKK-FITC
(3) K8L9-TAMRA: KLLLKLLKKLLKLLKKK-TAMRA
(4) Melittin: GIGAVLKVLTTGLPALISWIKRKRQQ-OH
(5) Melittin-FITC: GIGAVLKVLTTGLPALISWIKRKRQQ-FITC
(6) K6L9: LKLLKKLLKKLLKLL-NH2
(7) Magainin 2: GIGKFLHSAK KFGKAFVGEIMNS-OH.Chemistry & Biology 21, 1522–153Endocytosis Inhibition Assay
Cells were pretreated with endocytosis inhibitors (0.75–1.00 mM cytochalasin
D or 10 mM chlorpromazine) for 1 hr at 37C in 96-well plates. The cells were
incubated with different concentrations of peptides in 100 ml of medium for
24 hr at 37C. Cell viability was then determined using WST-8 solution (Cell
Count Reagent SF; Nacalai Tesque).
Cellular Uptake Analysis
Cells pretreated with endocytosis inhibitors were incubated with 3 mM K8L9-
FITC or 1 mM melittin-FITC for 1 hr at 37C. They were then collected and
rinsed in 0.1 M sodium acetate buffer with 0.05 M NaCl (pH 5.5) to remove sur-
face-bound FITC-labeled peptides (Mercer et al., 2010; Ohara et al., 2013) and
analyzed using a LSR Fortessa cell analyzer (BD Biosciences).
Western Blotting
Western blot analyses were carried out as described previously (Kawamoto
et al., 2013; Honjo et al., 2014). Briefly, protein extracts were prepared from
cells lysed with lysis buffer (Promega), separated by SDS-PAGE, and trans-
ferred to nitrocellulose filters using the iBlot system (Invitrogen) according to
the manufacturer’s protocol. Blocked membranes were probed with anti-
bodies and analyzed using Chemi-Lumi One Super reagent (Nacalai Tesque)
and a LAS-3000 LuminoImage analyzer (Fujifilm).2, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1529
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After incubation for 1 hr in the presence or absence of 5 mM K8L9-biotin or
1 mM melittin-biotin, cells were washed twice with ice-cold PBS, scraped
using a cell scraper, and collected by centrifugation at 300 g for 5 min. The
pellet was lysed with M-PER (Mammalian Protein Extraction Reagent; Pierce)
containing protease inhibitors. The protein content of cell lysates was deter-
mined using the Bio-Rad Protein Assay. Cell lysate containing 0.5–1.0 mg
protein was incubated with 30–60 ml NeutrAvidin Agarose Resin solution
(Pierce) at 4C for overnight. The resin was collected by centrifugation,
washed three times with Tris-buffered saline containing 0.03% Tween 20,
and then boiled in SDS-PAGE sample buffer at 95C for 5 min. The samples
were separated by SDS-PAGE, and proteins were visualized using Sil-Best
Stain One (Nacalai Tesque). Proteins were detected by immunoblotting, as
described above.
Mass Spectrometry and Protein Identification
Products of gel trypsin digestionwere suspended in 0.1% formic acid and sub-
jected to LC-MS/MS analysis. For the analytical separation, a NanoLC-Ultra-
2D Plus system with cHiPLC Nanoflex (Eksigent) was used in trap-and-elute
mode, with a trap column (200 mm 3 0.5 mm ChromXP C18-CL 3 mm 120 A˚;
Eksigent) and an analytical column (75 mm 3 15 cm ChromXP C18-CL 3 mm
120 A˚; Eksigent). Mobile phases used were 0.1% formic acid (loading solvent),
2% acetonitrile/0.1% formic acid (solvent A), and 80% acetonitrile/0.1%
formic acid (solvent B). The gradient program for the separation was from
2% solvent B to 40% solvent B in 50min. The separated samples were directly
introduced into the TripleTOF 5600 system fittedwith Nanospray III (AB SCIEX)
for information-dependent data acquisition. Acquired data sets were analyzed
by ProteinPilot software (AB SCIEX) using Paragon algorithm and a combined
database of the UniProtKB/Swiss-Prot and known contaminants (AB SCIEX).
The reliability of the protein identification was evaluated by the Unused Prot-
Score for each protein, which was calculated by the Pro Group algorithm
(AB SCIEX).
Measurement of Cathepsin B Activity
To measure cytosolic enzyme activity, cells were treated with an extraction
buffer (250 mM sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM
EDTA, and 1 mM pefabloc [pH 7.5]) containing 15 mg/ml digitonin for 12–
15 min on ice. To measure the total cellular cathepsin B activity, cells were
treated with the aforementioned extraction buffer containing 200 mg/ml digi-
tonin for 12–15 min on ice. The cellular extracts were incubated with 50 mM
of z-RR-AMC (7-amino-4-methylcoumarin; Peptide Institute) in cathepsin
reaction buffer (50 mM sodium acetate, 4 mM EDTA, 8 mM DTT, 1 mM pefa-
bloc [pH 6.0]) for 1 hr at 4C (Nylandsted et al., 2004). Cathepsin B activity
was measured by quantifying emission at 460 nm (excitation at 390 nm) using
GloMax-Multi+ Detection System (Promega).
Localization of K8L9 in Living Cells
A total of 1 3 104 cells per well was seeded in eight-well chamber slides and
incubated for 24 hr in RPMI 1640 medium containing 10% fetal bovine serum
v/v. The cells were then incubated with 10 mM K8L9-TAMRA peptide in 200 ml
of medium for 3 hr at 37C. The cells were subsequently stained with LTG
(Invitrogen) and Hoechst 33342 for 5 min and visualized using a FV1000 laser
scanning confocal microscope (Olympus).
Lysosomal Volume and Permeability Assessment
To label lysosomal compartments, cells were incubated with 0.5 mM LTG for
5 min at 37C and washed twice with PBS. Fluorescence integrity was evalu-
ated using a LSR Fortessa cell analyzer.
Other Methods
For the remaining experimental procedures and a more detailed description of
the above procedures, see Supplemental Experimental Procedures.
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